profit from every $100 of sales.
$0$100
PAVmed
$1.63+21.73% today
-84.6% in 1 year
1-year low $1.341-year high $12.05
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $32.50 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What PAVmed sold, what it kept, and what it did with the cash.
Sales went from $377,000 in 2022 to $71,000 in 2025, with $401,000 of profit last year.
SalesProfit
PAVmed vs. similar companies
PAVmed grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| PAVmed | 32.5× · Expensive | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads PAVmed's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 2 | 3 | 0 | |
| -3 | -4 | -2 | -0 | |
| -91 | -69 | -44 | -21 | |
| -100 | -76 | 30 | -2 | |
| -89 | -64 | 40 | 0 | |
| -450.90 | -274.80 | 15.00 | 1.84 | |
| -858.6% | -161.8% | -61.6% | -207.0% | |
| -24,161.0% | -2,805.7% | -1,481.7% | -30,126.8% | |
| -23,602.9% | -2,617.3% | 1,328.6% | 564.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 54 | 33 | 31 | 39 |
| Cash | 40 | 20 | 1 | 2 |
| Total debt | 37 | 49 | 32 | 13 |
| Total liabilities | 43 | 57 | 38 | 17 |
| -10 | -54 | -2 | 34 | |
| 0 | 0 | 0 | 1 | |
| -298.8% | – | 76.6% | -4.1% | |
| 919.2% | 119.2% | -1,594.8% | 1.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -71 | -52 | -34 | -5 | |
| 2 | 0 | 0 | 0 | |
| -73 | -52 | -34 | -5 | |
| Dividends paid | – | – | – | – |
| 0 | 0 | – | – | |
| 20 | 11 | 6 | 2 |
Valuation
- 32.5×
- –
- –
- 0.2×
- 183.6×
- –
- –
- -40.2%
- 3.1%
- 0.0%
Profitability
- -207.0%
- -30,126.8%
- 564.8%
- -9,005.6%
- -61.2%
- 196.1%
- 1.0%
- 1.0%
- -91.0%
- 6,328.2%
Growth
- −42.7%
- –
- −15,389.9%
- –
- +40.5%
Financial health
- –
- 0.39
- 34.4%
- -1,038.5×
- 0.17
- 0.17
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 4%of 952
Bottom 39%of 601
Bottom 2%of 886
Bottom 1%of 987
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 15, 2026 | -1.17 | -0.69 | −69.6% |
| Mar 26, 2026 | -2.05 | -4.50 | +54.4% |
| Nov 13, 2025 | -8.41 | -6.01 | −39.9% |
| Aug 14, 2025 | -0.05 | -0.25 | +80.0% |
| May 15, 2025 | -0.07 | -0.29 | +75.9% |
| Mar 25, 2025 | -0.06 | -0.40 | +85.0% |
| Nov 13, 2024 | -0.54 | -1.30 | +58.5% |
| Aug 13, 2024 | -0.84 | -1.45 | +42.1% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
42No pass
Benjamin Graham
49No pass
Philip Fisher
58No pass
Peter Lynch
39No pass
Joel Greenblatt
11No pass
Charlie Munger
39No pass
Terry Smith
39No pass
Questions about PAVmed
Is PAVmed a good stock to buy?
A strong, very profitable business, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the PAVmed AI analysis
What does PAVmed do?
PAVmed Inc. operates as a medical device company in the United States. It is in Medical - Devices.
Does PAVmed pay a dividend?
No. PAVmed does not pay a dividend at the moment.
Is PAVmed stock halal?
No. PAVmed does not pass our halal screen: its debt is 102% of its market value, at or above the 33% limit. How we check
How has PAVmed stock done over the past year?
Down 84.6% over the past twelve months, to $1.63. It traded between $1.34 and $12.05 and is 86.5% below its high.
Who are PAVmed's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with PAVmed's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.